KRISHANA Krishana Phoschem Q4 FY25 results (Jan–Mar 2025) and concall
Krishana Phoschem delivered a strong Q4 and full-year FY25 performance, marked by robust revenue and profit growth driven by increased volumes and improved operational efficiency. The company saw significant increases in SSP and NPK/DAP sales and utilization, with full-year PAT more than doubling. Management outlined plans for capacity expansion and product innovation, while acknowledging that future margin expansion might be limited due to raw material and subsidy dynamics.
You’re reading a preview. Opening the full call uses 1 concall credit.
Sign in to use your monthly call allowance.
What they filed
| Line item | Q2 FY25 | Q3 FY25 | Q4 FY25 |
|---|---|---|---|
| Revenue | 301 | 304 | 473 |
| EBITDA | 40 | 44 | 56 |
| Net profit | 17 | 21 | 33 |
How to read this
₹ crore, as filed. The percentage beside a figure is the change against the same quarter a year earlier — never the quarter before, which would make every seasonal business look like it collapses and booms each year.
Inve summary of a publicly available earnings call transcript; see how call summaries are prepared. Not investment advice.
